US 10167292
Benzodiazepines as bromodomain inhibitors
granted A61PA61P29/00A61P35/00
Quick answer
US patent 10167292 (Benzodiazepines as bromodomain inhibitors) held by Catalyst Therapeutics Pty Ltd. expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Catalyst Therapeutics Pty Ltd.
- Grant date
- Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P29/00, A61P35/00, A61P37/02, A61P43/00